Here are relevant reports on : ai-in-drug-discovery-discovery-market

• US Generative AI Market by Software (Foundation Models, Model Enablement & Orchestration Tools, Gen AI SaaS), Modality (Text, Code, Video, Image, Multimodal), Application (Content Management, BI & Visualization, Search & Discovery) - Forecast to 2032

  The US generative AI market size is projected to grow from USD 25.78 billion in 2025 to USD 279.44 billion by 2032, at a CAGR of 40.6% during the forecast period.The Key Players include IBM (US), NVIDIA (US), OpenAI (US), Anthropic (US), Meta (US), HPE (US), AMD (US), Oracle (US), Innodata (US), iMerit (US), Salesforce (US), Telus Digital (US), Microsoft (US), Google (US), AWS (US), Adobe (US), Certific (US), Fractal Analytics (US), Tiger Analytics (US), Quantiphi (US), Databricks (US), Dialpad (US), Simplified (US), Hugging Face (US), Persado (US), Copy.AI (US), Synthesis AI (US), Hypotenuse AI (US), Together AI (US), Adept (US), Writesonic (US), Inflection AI (US), Jasper (US), Runway (US), Inworld AI (US), Typeface (US), H2O.ai (US), Speechify (US), Midjourney (US), FireFiles (US), Forethought (US), Character.AI (US), Cursor (US), DeepSeek (US), XAI (US), Abridge (US), Perplexity AI (US), SambaNova (US), Scale AI (US), Labelbox (US), and HQE Systems (US).

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• Generative AI Market by Software (Foundation Models, Model Enablement & Orchestration Tools, Gen AI SaaS), Modality (Text, Code, Video, Image, Multimodal), Application (Content Management, BI & Visualization, Search & Discovery) - Global Forecast to 2032

  The generative AI market is experiencing a seismic growth trajectory, projected to surge from USD 71.36 billion in 2025 to USD 890.59 billion by 2032, at a CAGR of 43.4% during the forecast period. The major players in the generative AI market include IBM (US), NVIDIA (US), OpenAI (US), Anthropic (US), Meta (US), HPE (US), AMD (US), Oracle (US), Innodata (US), iMerit (US), Salesforce (US), Telus Digital (US), Microsoft (US), Google (US), AWS (US), Adobe (US), Accenture (Ireland), Capgemini (France), Centific (US), Fractal Analytics (US), Tiger Analytics (US), Quantiphi (US), Databricks (US), Dialpad (US), Appen (Australia), Insilico Medicine (Hong Kong), Simplified (US), AI21 Labs (Israel), Hugging Face (US), Persado (US), Copy.ai (US), Synthesis AI (US), Hypotenuse AI (US), Together AI (US), Mistral AI (France), Adept (US), Stability AI (UK), Lightricks (Israel), Cohere (Canada), Writesonic (US), Inflection AI (US), Colossyan (UK), Jasper (US), Runway (US), Inworld AI (US), Typeface (US), Upstage (South Korea), H2O.ai (US), Speechify (US), Midjourney (US), Fireflies (US), Synthesia (UK), Mostly AI (Austria), Forethought (US), Character.ai (US), Cursor (US), DeepSeek (China), XAI (US), Abridge (US), Perplexity AI (US), SambaNova (US), Scale AI (US), Labelbox (US), and HQE Systems (US).

  • Published: May 2025
  • Price: $ 7150
  • TOC Available:

• Causal AI Market by Offering (Causal AI Platforms, Causal Discovery, Causal Inference, Causal Modelling, Root Cause Analysis), Application (Financial Management, Sales & Customer Management, Operations & Supply Chain Management) - Global Forecast to 2030

  The causal AI market is projected to reach USD 456.8 million by 2030, expanding at a CAGR of 41.8% during the forecast period. The major players in the Causal AI market include IBM (US), Logility (US), CausaLens (UK), Aitia (US), Causely (US), Geminos (US), along with SMEs and startups such as Data Poem (US), CausaAI (Netherlands), Causa (UK), Lifesight (US), amd Actable AI (UK).

  • Published: December 2024
  • Price: $ 4950
  • TOC Available:

• Single-molecule Real-time (SMRT) Sequencing Market by Offering (Products, Services), Workflow (Sequencing, Data Analysis), Application (Drug Discovery, Diagnostic, Agriculture), End User (Academia, Pharma, Biotech) - Forecast to 2030

  The Single-molecule Real-time (SMRT) Sequencing Market, valued at US$2.83 billion in 2024, stood at US$2.92 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2025 to 2030, culminating in a forecasted valuation of US$5.32 billion by the end of the period. This market is expanding as long-read sequencing is used more often in rare disease diagnostics, cancer genomics, and broader precision medicine programs.

  • Published: December 2025
  • Price: $ 4950
  • TOC Available:

• Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029

  The global gene expression analysis market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.

  • Published: March 2024
  • Price: $ 4950
  • TOC Available:

• Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028

  The global pharmacogenomics market, valued at US$3.3 billion in 2022, stood at US$3.5 billion in 2023 and is projected to advance at a resilient CAGR of 10.6% from 2023 to 2028, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market.

  • Published: February 2024
  • Price: $ 4950
  • TOC Available:

• CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030

  The global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years.

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• Immune Repertoire Sequencing Market by Product (Instrument, Software, Assay Kit & Reagent (TCR, BCR Kit)), Technology (Sequencing, Bioinformatics), Service (Data Analysis), Application (Research, Drug Discovery & Development) - Global Forecast to 2030

  Global immune repertoire sequencing market valued at $344.2M in 2024, reached $354.6M in 2025, and is projected to grow at a robust 9.6% CAGR, hitting $560.5M by 2030. The growth of the Asia Pacific IRS market is primarily due to growing R&D investments and the increasing presence of major industry stakeholders in the region.

  • Published: April 2025
  • Price: $ 4950
  • TOC Available:

• Federated Learning Market by Application (Drug Discovery, Industrial IoT, Risk Management), Vertical (Healthcare and Life Sciences, BFSI, Manufacturing, Automotive and Transportation, Energy and Utilities) and Region - Global Forecast to 2028

  As per AS-IS scenario, the global federated learning market size is projected to reach worth $210 million by 2028, at a Compound Annual Growth Rate (CAGR) of 10.6% during the forecast period. The federated learning solutions vendors have implemented various types of organic as well as inorganic growth strategies, such as new product launches, product upgradations, partnerships and agreements, business expansions, and mergers and acquisitions to strengthen their offerings in the market. The major vendors in the global federated learning solutions market include NVIDIA (US), Cloudera (US), IBM (US), Microsoft (US), Google (US), Intel(US), Owkin(US), Intellegens(UK), Edge Delta(US), Enveil(US), Lifebit(UK), DataFleets(US), Secure AI Labs(US), and Sherpa.AI(Spain).

  • Published: April 2022
  • Price: $ 4950
  • TOC Available:

• Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

  The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.

  • Published: September 2014
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS
• NEXT
• LAST

Records 11 to 20 of 50